Equity awards granted to RCKT director and 10% owner Roderick Wong
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
ROCKET PHARMACEUTICALS, INC. director and 10% owner Roderick Wong received new equity awards in the form of common stock and options. He was granted 27,832 restricted stock units that convert into common shares on a one-for-one basis and vest in full on June 18, 2027. He also received a stock option for 78,960 shares of common stock at an exercise price of $3.35 per share, which becomes fully vested and exercisable on June 18, 2027 and expires on June 18, 2036. Following these awards, he holds 75,499 common shares directly and 18,188,457 shares indirectly through investment funds managed by RTW Investments, LP.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
WONG RODERICK
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 78,960 | $0.00 | -- |
| Grant/Award | Common Stock | 27,832 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 78,960 shares (Direct, null);
Common Stock — 75,499 shares (Direct, null);
Common Stock — 18,188,457 shares (Indirect, See footnote)
Footnotes (1)
- Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027. Represents shares held by certain investment funds managed by RTW Investments, LP (the "Adviser"). The Reporting Person serves as the Managing Partner and Chief Investment Officer of the Adviser and is a director of the Issuer and Chairman of the Issuer's Board of Directors. This option represents a right to purchase a total of 78,960 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027.
Key Figures
RSUs granted: 27,832 units
Option shares granted: 78,960 shares
Option exercise price: $3.35 per share
+3 more
6 metrics
RSUs granted
27,832 units
Restricted stock units vesting June 18, 2027
Option shares granted
78,960 shares
Stock option grant on June 18, 2026
Option exercise price
$3.35 per share
Stock option (Right to Buy) for common stock
Option expiration
June 18, 2036
Expiration date of 78,960-share stock option
Direct common shares after award
75,499 shares
Total Rocket common stock held directly after transactions
Indirect common shares
18,188,457 shares
Shares held by funds managed by RTW Investments, LP
Key Terms
restricted stock units, Stock Option (Right to Buy), indirect ownership, RTW Investments, LP, +1 more
5 terms
restricted stock units financial
"Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 3.3500."
indirect ownership financial
"Common Stock entry marked as indirect with nature of ownership "See footnote"."
RTW Investments, LP financial
"Represents shares held by certain investment funds managed by RTW Investments, LP (the "Adviser")."
Managing Partner and Chief Investment Officer financial
"The Reporting Person serves as the Managing Partner and Chief Investment Officer of the Adviser."
FAQ
What equity awards did Roderick Wong receive from Rocket Pharmaceuticals (RCKT)?
Roderick Wong received 27,832 restricted stock units and a stock option for 78,960 Rocket Pharmaceuticals shares. The RSUs convert one-for-one into common stock, while the option allows future purchases at a fixed $3.35 per share exercise price.
When do Roderick Wong’s new Rocket Pharmaceuticals (RCKT) RSUs and options vest?
Both the 27,832 restricted stock units and the option for 78,960 shares vest fully on June 18, 2027. Once vested, RSUs convert into common shares and the option becomes exercisable until its June 18, 2036 expiration date.
What is the exercise price and expiration date of Roderick Wong’s new RCKT stock option?
The new stock option covers 78,960 Rocket Pharmaceuticals shares at a $3.35 exercise price. It becomes fully exercisable on June 18, 2027 and remains exercisable until its stated expiration date of June 18, 2036, subject to plan terms.
What are the restricted stock units (RSUs) granted to Roderick Wong by Rocket Pharmaceuticals (RCKT)?
The 27,832 RSUs granted to Roderick Wong each convert into one Rocket Pharmaceuticals common share. They vest in full on June 18, 2027, meaning he will receive the underlying common stock if he meets the vesting conditions through that date.